Clinical Trial Update: A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study evaluating the safety and preliminary efficacy of GSK5460025 alone or in combination with other anti-canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Neoplasms

Drugs mentioned

• GSK5460025

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Colorectal, Neoplasms | Phase 1, Phase 2 | Status: RECRUITING